PDS Biotechnology Corp - Common Stock, par value $0.00033 per share (PDSB)

CUSIP: 70465T107

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+477,794
Put/Call ratio
207%
SEC-reported price per share
$4.97
Number of holders
74
Value change
+$2,355,421
Number of buys
38
Open additional details 1 more signal available
Number of sells
31
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
102,192,638

Security key

70465T107

Report period

Q4 2023

Institutions

74

Top holders

10

Ownership snapshot

Top reported holders of PDSB - PDS Biotechnology Corp - Common Stock, par value $0.00033 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F 3/4/5 Highest disclosed value: $9,107,589 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $9.11M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $9.11M
DeLyle W. Bloomquist $7.81M
VANGUARD GROUP INC $7.61M
GEODE CAPITAL MANAGEMENT, LLC $3.04M
STATE STREET CORP $2.55M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$9,107,589
1,803,483 shares
— 30 Sep 2023
DeLyle W. Bloomquist
3/4/5
Resigned as a Director on June 17, 2021.
—
mixed-class rows
$7,813,350
804,941 shares
mixed-class rows
— 16 Jun 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$7,613,839
1,507,691 shares
— 30 Sep 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$3,037,273
601,360 shares
— 30 Sep 2023
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$2,549,952
504,941 shares
— 30 Sep 2023
TANG CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$2,020,000
400,000 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
74
Shares
8,335,087
Rows available
74
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
78
Q4 2023 holders
74
Holder diff
-4
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .